Loading...
XSHE
003042
Market cap345mUSD
Dec 05, Last price  
17.15CNY
1D
-2.50%
1Q
3.38%
IPO
-34.74%
Name

Shandong Sino-Agri United Biotechnology Co Ltd

Chart & Performance

D1W1MN
XSHE:003042 chart
P/E
P/S
1.21
EPS
Div Yield, %
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
8.06%
Revenues
2.01b
+19.79%
907,296,054952,313,1051,121,754,3551,412,800,6431,366,782,4151,568,185,2771,625,072,6141,933,423,7761,680,905,1542,013,624,015
Net income
-122m
84,264,72072,898,024106,467,246243,671,414147,136,392103,525,72898,594,92373,137,8540-122,453,099
CFO
105m
+20.71%
41,835,03980,407,236244,279,044242,667,71296,221,623114,723,31554,407,865086,903,287104,897,433
Dividend
Jun 21, 20230.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shandong Sino-Agri United Biotechnology Co.,Ltd. engages in the development and production of agricultural chemicals and pesticides in China. The company's products include insecticide, such as imidacloprid and acetamiprid; intermediates comprising ethyl n-cyanoethanimideate and n-nitroimino imidazolidine; fungicides, including diethofencarb and myclobutanil1; acaricide, such as fenpyroximate and pyridaben1; and crude drugs and preparation products, and herbicides. It also provides technical consulting services; and exports its products to Southeast Asia, South Asia, the Middle East, Europe, and the United States. The company was founded in 2006 and is based in Jinan, China.
IPO date
Apr 06, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT